The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2017 | Getting specific with myeloma therapy: selecting the right treatments
Saad Usmani
• 24 Jun 2017
There are so many new and existing agents, regimes, combinations to and mechanisms to consider when treating myeloma patients. Dr Saad Z Usmani, Carolinas Healthcare System, Charlotte, NC, tells us what’s happening within the clinical research community to tackle these challenges during the European Society of Hematology meeting in Madrid.
